|
SCAMP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.771070E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.37760000000909E-05 |
| Normal-vs-Stage2 |
4.079800E-02 |
| Normal-vs-Stage3 |
8.558300E-02 |
| Normal-vs-Stage4 |
1.522210E-01 |
| Stage1-vs-Stage2 |
6.692200E-01 |
| Stage1-vs-Stage3 |
4.546200E-01 |
| Stage1-vs-Stage4 |
7.726400E-01 |
| Stage2-vs-Stage3 |
8.289200E-01 |
| Stage2-vs-Stage4 |
9.789600E-01 |
| Stage3-vs-Stage4 |
8.495200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.035900E-04 |
| Normal-vs-AfricanAmerican |
1.132070E-02 |
| Normal-vs-Asian |
8.371200E-01 |
| Caucasian-vs-AfricanAmerican |
6.643600E-01 |
| Caucasian-vs-Asian |
1.783810E-01 |
| AfricanAmerican-vs-Asian |
2.360200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.32729999996673E-06 |
| Normal-vs-Female |
4.638200E-01 |
| Male-vs-Female |
7.101700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.617700E-02 |
| Normal-vs-Extreme_Weight |
1.627390E-04 |
| Normal-vs-Obese |
9.543400E-03 |
| Normal-vs-Extreme_Obese |
1.280840E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.978600E-01 |
| Normal_Weight-vs-Obese |
7.681000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.464600E-01 |
| Extreme_Weight-vs-Obese |
2.425000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.097200E-01 |
| Obese-vs-Extreme_Obese |
3.344800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.647430E-01 |
| Normal-vs-Age(41-60Yrs) |
1.123790E-02 |
| Normal-vs-Age(61-80Yrs) |
5.93059999999257E-05 |
| Normal-vs-Age(81-100Yrs) |
5.696300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.249000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.139000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.495600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.159400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.039600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.499800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.15630000000022E-06 |
| Normal-VS-Type2 PRCC |
8.517700E-03 |
| Normal-VS-KIRP CIMP |
5.039000E-01 |
| Normal-VS-Unclassified PRCC |
2.961800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.159200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.295400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.769230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.769400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.781600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.463200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.684830E-03 |
| Normal-vs-N1 |
1.084220E-01 |
| Normal-vs-N2 |
9.188600E-01 |
| N0-vs-N1 |
3.936400E-01 |
| N0-vs-N2 |
3.547600E-01 |
| N1-vs-N2 |
5.761200E-01 |
|
|
